Progenics Pharmaceuticals Inc. (PGNX)

All Comments on PGNX

  • commenter
    PrudentMan,
    CFA
    Jun 24 11:54 AM
    22 Stocks Going Ex-Dividend in Early July [view article]
    Great Service. Thanks! Reply
  • commenter
    hendi_alex
    Jun 24 08:51 AM
    My Website
    22 Stocks Going Ex-Dividend in Early July [view article]
    Here is a site that has a fairly complete and accurate listing of stocks going ex. dividend on a specific date.

    www.companyboardroom.c...     Reply
  • commenter
    Marol
    Apr 19 02:44 AM
    Q1's Best and Worst Performing Stocks [view article]
    Thank you! As a basically-momentum investor (I have to like the stock otherwise, too) I find these compilations very helpful indeed. Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:17 AM
    My Website
    General Discussion on PGNX
    Is this a buy or a sell? Reply
  • commenter
    paultaut
    Apr 01 05:57 PM
    Insider Buying in Biotech Land [view article]
    you watch insider buying, so do I, but they are notoriously early....

    Suggest you look at SCLN.     Reply
  • commenter
    Fat Arby
    Mar 13 05:12 PM
    My Website
    Thursday's Options Report: GDX, F, PGNX, DIA, XLF, IWO, IWD [view article]
    Agreed Reply
  • commenter
    Lisa
    Mar 13 02:23 PM
    Thursday's Options Report: GDX, F, PGNX, DIA, XLF, IWO, IWD [view article]
    Excellent survey. Reply
  • commenter
    harrymae
    Jun 06 10:57 AM
    Companies With The Most Analyst Attention & Affection [view article]
    When good stocks with a good balance sheet and incomestqtement fall, then the quality of the company and the price of theat stock are in disconnect.
    The flow of money seems fickle!
    H. Sutcliffe     Reply
  • commenter
    Josh Stern
    Jun 05 09:48 PM
    Companies With The Most Analyst Attention & Affection [view article]
    When analyst's change their ratings it tends to move stocks. So ideally one would measure stock performance in some window starting just after whatever analyst condition is being measured. In contrast, you give YTD statistics for stocks that are all buys but they were not all buys at the start of the year. Reply
  • commenter
    CTA
    Jun 05 05:18 PM
    Companies With The Most Analyst Attention & Affection [view article]
    Have you guys run anything on the other side of the list -- the companies with low to no coverage? Reply
  • commenter
    marcel.tony
    Apr 02 10:22 AM
    Biotech Day In Review: Novartis Pulls Zelnorm Off The Market [view article]
    Astellas is quite right : REGN has fantastic monoclonal technology. Rather than manipulate the Fc fragment, they know how to manipulate the moieties of the receptors linked to it. This is unique.
    Have a look at a picture that hopefully makes this a bit more simple to understand :
    www.healthvalue.net/VE...     Reply
Loading...
Symbols:
Authors:
Quick Links: